Johnson & Johnson (JNJ)
Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.
Recs
Upthumb. Very good sales growth and payout. Low sales growth of 6.9% over 5 years. LIkely to be flat this year. High quick ratio and low debt ratio with AAA rating. What will drive the stock higher, though is the pipeline which is filled with 10 very good drug candidates.
Recs
JNJ is a world-class consumer goods company that throws off monstrous cash flows each year. The Pfiezer Consumer deal will contribute to the top and bottom line. Strong cost control and more than 30 drugs in phase III trials provide the fuel for an upside surprise on the bottom line. The dividend, management and inelastic demand for the company’s products should insolate the firm from an economic cooling.
Recs
tough call, with Dems in control, pharms have to work so much harder. Excellent company.
Recs
Bought due to decent dividend return and long term potential.
Recs
j & j is a darling and a must to have in the
portfolio
Recs
I decided to create a portfolio with only products or services that I use without regard to price/value in order to compare with my own personal port
Recs
JNJ is diversified and mature enough to weather most "Pharm" issues. I'm holding long term
Recs
Democratic control
Recs
I'm just here for the dividends.
Recs
A solid company that will pay you a 3% dividend while you're waiting for the market to recover at which time JNJ will be among the leaders.
Recs
Johnson and Johnson has won my heart back when I was in diapers. That baby powder had no equal. :]]
Recs
They have an excellant policy of helping people without insurance or low incomes. Their service is great and fast and the operators helpful and friendly. They are easy to work with according to many doctors. All this leads to free advertising by customers, who will buy their other products based on the help they recieved for their medicines. Being nice still pays even in big business.
Recs
Very strong, diversified company that can weather a choppy market going forward.
Recs
we are getting older and living longer, need i say more. look at the companies history and managment its a winner
Recs
bird flu paranoia will get this stock rolling
Recs
This Company has been a american household name for many decades if not centuries yet. The Current rise in fuel is moving everything up to make up the diffirence.
Recs
Recs
Recs
There is a lot of negative sentiment surrounding large cap stocks because they hardly made any price action over a considerable time-span.
What investors forget is that in the meantime intrinsic value increases in lock step with their increase in free cash flow. An effectively static price means that the discrepancy between price and value increases.
This is fantastic news for the buy side.
Recs
At a P/E of 16, and God only know when it cut or didn't raise its divdend, I think this is definately a defensive Widows and Orphans stock that has enough of a kicker for most people! The only down side is at what stage will the law of large numbers kick in? You can't grow add infinitum at 9% can you? Food for thought!

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 1986 1 2 3 4 5 6 7 8 9 10 Next »